Experimental Section
Methods and materials
Materials
The monomer 2-hydroxypropyl methacrylate (mixture of isomers, HPMA) was purchased from Alfa Aesar and was passed through a column of basic alumina prior to use. The synthesis of the PEG 113 mCTA from PEG 113 monomethyl ether and 4-cyano-4-(((ethylthio)carbonothioyl)thio)pentanoic acid (CEPA) has been described in a previous report.
[ 1] The reagents L-asparagine, fetal bovine serum (FBS), Nessler's reagent and GFP was expressed as previously reported. [3] Human lung carcinoma A549 cells were purchased from Public Health England. PrestoBlue ® cell viability reagent and anti-mouse IgG secondary antibody conjugated with alkaline phosphatase were acquired from Invitrogen, L-asparaginase synthetase siRNA (h) (sc-60212)
or control siRNA-A (sc-37007), using siRNA transfection reagent (sc-29528) and siRNA transfection medium (sc-36868), and L-asparagine synthetase (G-10) antibody (sc-365809)
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were purchased from Santa Cruz Biotechnology and used according to the supplier's instructions.
Characterization techniques DLS analysis of the vesicles was performed on a Malvern Zetasizer Nano ZS instrument.
Purified samples were diluted with filtered deionized water (0.45 µm, nylon) and the diluted samples were not filtered prior to analysis so as to ensure larger structures remained in solution. Average z-average hydrodynamic radii (D H ) were calculated from 5 repeat measurements. vesicles was as follows. [2, 3] PEG 113 mCTA (9.1 mg) was dissolved in deionized water (800 µL) and HPMA (100 mg) was then added. Once homogeneous, 100 µL of a 200 U mL vesicles, a recently reported method by our group was followed. [3] Purified GFP-loaded vesicles were then used for cell internalization studies.
Enzymatic activity assays
Activity of ASNS-loaded vesicles. The purified sample at 10× dilution from the initial PISA synthesis in deionized water (1 mL), was diluted with 50 mM pH 8.6 Tris buffer (1 mL) and 95 mM L-asparagine (200 µL) was added. This was incubated at 37 °C for 30 min, followed by the addition of 1.5 M trichloroacetic acid (100 µL). The sample was clarified by centrifugation (16,000 × g for 10 min) and the clear supernatant (170 µL) was added to a 96-well plate. Nessler's reagent (30 µL) was then added and the absorbance at 485 nm was read using a plate reader. For the photograph of the wells in Figure 2A , the wells containing S6 supernatants from the purification were prepared in an identical manner but the final 96-well plate contained the clarified supernatant (20 µL), deionized water (150 µL) and Nessler's reagent (30 µL).
Activity of ASNS-loaded vesicles in the presence of α-CT.
The purified sample at 10× dilution from the initial PISA synthesis in deionized water (5 mL) was incubated at room temperature with either 50 mg mL -1 α-CT (0.5 mL) or deionized water (0.5 mL). Aliqouts of 800 µL were taken after 18 h or 7 days and their activity immediately assessed by dilution with 50 mM pH 8.6 Tris buffer (1 mL) and the addition of 95 mM L-asparagine (200 µL). After incubation at 37 °C for 30 min, followed by the addition of 1.5 M trichloroacetic acid (100 µL), the sample was clarified by centrifugation (16,000 × g for 10 min). The clear supernatant (20 µL) was diluted with deionized water (150 µL) in a 96-well plate. Nessler's reagent (30 µL) was then added and the absorbance at 405 nm was read using a plate reader. For the free ASNS and the free PEG-ASNS, a 0.18 U mL -1 solution (corresponding to an encapsulation efficiency of 9%) in deionized water (5 mL) was incubated at room temperature with either 50 mg mL -1 α-CT (0.5 mL) or deionized water (0.5 mL) and the solutions' activities assessed in an identical manner.
Calculation of loading efficiencies
Western blot analysis of the enzyme-loaded vesicles. In a typical experiment using ASNSloaded vesicles, the sample was mixed in a 1:1 ratio with SDS loading buffer, followed by heating and shaking for 15 min at 80 °C using a thermomixer. The sample was ran on a 4-20% poly(acrylamide) gel at 200 V and 400 mA for 30 min using tris glycine SDS as the running buffer. The gel was transferred to a nitrocellulose membrane using 20% methanol tris glycine as the transfer buffer at 100 V and 400 mA for 45 min. The membrane was washed with tris buffered saline (TBS)/tween and incubated for 1 h with milk/TBS/tween. The membrane was then incubated with rabbit anti-asparaginase (biotin conjugated) in milk/TBS/tween at an antibody dilution of 1:1,000 overnight. After washing 3 times with TBS/tween, the membrane was incubated with goat anti-rabbit IgG H+L (HRP conjugated) in milk/TBS/tween at an antibody dilution of 1:1,000 for 1 h. After washing 3 times with TBS/tween, the membrane was incubated with a luminol/peroxide chemiluminescent reagent for 2 minutes, followed by digital visualization using a 30 s exposure time.
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Western blot data processing. The pixel area of each band was determined using ImageJ software and a calibration curve for each enzyme was determined using the dilution series of known concentration. This allowed for the determination of the sample protein concentration using the measured pixel area of the sample protein band.
Stability studies of empty and ASNS-loaded vesicles in complex media
To assess the colloidal stability of empty and ASNS-loaded PEG 113 -b-PHPMA 400 vesicles and their interaction with complex physiological media, a typical protocol was followed. [4] FBS and cell growth medium were first incubated at 37 
Antibody binding studies
Antibody binding was assessed using a sandwich ELISA assay. [5] Three dilution series of ASNS, PEG-ASNS and ASNS-loaded vesicles in buffer (pH 7.4, 100 mM phosphate, 150 mM NaCl) starting from 0.18 U mL -1 protein, were prepared. A typical procedure to assess anti-ASNS binding was as follows. Streptavin-coated wells were washed 3 times with 200 µL wash buffer (pH 7.4, 100 mM phosphate, 150 mM NaCl, milk) before being treated with 100 µL rabbit anti-ASNS (biotin conjugated) diluted 1,000 fold in wash buffer. After incubation at 4 °C for 18 h, the wells were washed 3 times with 200 µL wash buffer before being treated with 100 µL of the ASNS dilution series, PEG-ASNS or ASNS-loaded vesicles.
After 2 h incubation at room temperature, the wells were washed 3 times with 200 µL wash buffer before being treated with 100 µL anti-ASNS (HRP conjugated) diluted 1,000 fold in wash buffer. After 1 h incubation at room temperature, the wells were washed 6 times with 200 µL wash buffer before 3,3′,5,5′-tetramethylbenzidine liquid substrate (100 µL) was added to each well. After 10 min, 1 M hydrochloric acid (100 µL) was added to each well and the absorbance was measured at 405 nm. The relative affinity of anti-ASNS to each sample was calculated from the calibration curve of the dilution series. For anti-PEG binding, a similar protocol was followed using PEG-ASNS and ASNS-loaded vesicle dilution series. Anti-PEG S8 (biotin conjugated) and anti-PEG (HRP conjugated) were diluted 2,000 fold in wash buffer prior to incubation.
In vitro cell studies 
Cell viability results for empty and ASNS-loaded vesicles

S18
In vivo biodistribution data Figure S9 . Biodistribution data after 24 and 48 h of vesicles and free ASNS tagged with Cy5, obtained from ex vivo tissue analysis (Ex. = 630 nm, Em. = 700 nm). A statistically significant difference in clearance is observed for the enzyme when compared to the vesicles at 24 hours in both the liver (p*** < 0.0001) and kidneys (p** < 0.004) indicating faster clearance of the free enzyme due to reduced protection from the vesicles.
